Frag 176-191 is a synthetic peptide corresponding to amino acids 176-191 of human growth hormone. It promotes lipolysis while inhibiting lipogenesis, which is why it is commonly referred to as the “lipolytic fragment” of HGH.
Used to treat growth hormone deficiencies, Frag 176-191 aids in weight management while enhancing bone strength and muscle recovery. Researchers are now investigating applications of Frag 176-191 in the fields of fat loss, cartilage repair, and as a potential prediabetes and type 2 diabetes treatment.